Bristol Myers Squibb secures FDA nod for Breyanzi in marginal zone lymphoma
The one-time CAR T cell infusion now becomes the first and only therapy of its kind cleared for this patient population
The one-time CAR T cell infusion now becomes the first and only therapy of its kind cleared for this patient population
Ipca Laboratories receives three observations from USFDA for API facility at Tarapur
Terray and BMS aim to accelerate small molecule drug discovery by harnessing EMMI’s integrated experimental and AI capabilities
Senores Pharmaceuticals is poised to accelerate its presence in the Asia-Pacific region
Valorum will advance the commercialization and distribution of Armlupeg in the United States
The center will offer training to super-specialist doctors and healthcare professionals in various fields
This campaign is to raise awareness about the crucial role helmet usage plays in saving lives
Peapod Bio’s proprietary technologies can efficiently identify inhibitors and binding molecules for virtually any target
Growing patent filings and tier-2 innovators reflect expanding national research base
The partnership aims to combine TQx’s in vivo therapeutic expertise with Kytopen’s continuous flow transfection technology
Subscribe To Our Newsletter & Stay Updated